Overview
Hillenbrand fiscal Q3 rev falls 24% yr/yr, driven by MIME divestiture
Adjusted EPS for fiscal Q3 beats consensus despite a 40% yr/yr decline
Co achieved $30 mln cost synergies from Linxis and FPM acquisitions
Outlook
Hillenbrand maintains full-year adjusted EPS midpoint at $2.20-$2.35
Company expects fiscal 2025 adjusted EBITDA of $370 mln-$385 mln
Result Drivers
MIME DIVESTITURE - Revenue decreased 24% yr/yr primarily due to MIME divestiture
COST SYNERGIES - Achieved $30 mln cost synergies from Linxis and FPM acquisitions earlier than planned
TARIFF IMPACT - Customer purchasing decisions delayed due to dynamic tariff landscape
Key Details
Metric | Beat/Miss | Actual | Consensus Estimate |
Q3 Adjusted EPS | Beat | $0.51 | $0.49 (4 Analysts) |
Q3 Net Income | $2 mln | ||
Q3 Adjusted EBITDA | Miss | $84 mln | $85.40 mln (4 Analysts) |
Q3 Adjusted EBITDA Margin | 15.8% |
Analyst Coverage
The current average analyst rating on the shares is "buy" and the breakdown of recommendations is 2 "strong buy" or "buy", 2 "hold" and no "sell" or "strong sell"
The average consensus recommendation for the industrial machinery & equipment peer group is "buy"
Wall Street's median 12-month price target for Hillenbrand Inc is $34.00, about 42% above its August 8 closing price of $19.72
The stock recently traded at 9 times the next 12-month earnings vs. a P/E of 8 three months ago
Press Release: ID:nPn52zsdla
(This story was created using Reuters automation and AI based on LSEG and company data. It was checked and edited by a Reuters journalist prior to publication.)
Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.